Stemline Therapeutics Inc (NASDAQ:STML)

15.19
Delayed Data
As of Feb 27
 -1.01 / -6.23%
Today’s Change
10.50
Today|||52-Week Range
29.50
-10.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-1.8M-2.8M-6.3M-24.2M
 
 
 
 
 
Depreciation0.000.00--76.7K
 
 
Total Other Cash Flow47.6K108.3K611.0K5.3M
 
 
 
 
 
Funds From Operations-1.7M-2.5M-5.7M-18.8M
 
 
 
 
 
Funds From/For Other Operating Expenses189.4K-601.4K-1.5M-2.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-1.9M-1.9M-4.1M-16.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-40.2M
 
 
Capital Expenditures0.000.000.00-460.0K
 
 
Net Cash Flow Investing0.000.000.00-40.7M
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.00540.0K322.0K0.00
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale602.6K0.000.0099.0M
 
 
 
Common Preferred Redeemed-750.0K0.000.000.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-147.4K540.0K322.0K99.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash-2.0M-1.4M-3.8M42.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account